A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Emory University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center